13:35:11 EST Thu 15 Jan 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

C:PHRM - PharmaTher Holdings Ltd. - https://www.pharmather.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PHRM - C  43.20.09·0.09527.00.09-0.005-5.3180.915290.095  0.10  0.090.77  0.0913:11:14Jan 1415 min RT 2¢
CSE - C43.20.09·0.09527.00.09-0.005-5.368.0690.095  0.095  0.090.77  0.0913:11:1415 min
NEO ATS - U 0.09-0.005-5.332.02100.095  0.095  0.0913:11:1415 min
Omega - O 0.09-0.005-5.351.0550.10  0.10  0.0912:53:1515 min
CX2 - H 0.09-0.005-5.329.0320.09  0.09  0.0912:53:2215 min
CXD - D 0.0950.0021    Oct 1515 min
MatchNOW - M 0.0950.92    15 min

Recent Trades - Last 10 of 29
Time ETExPriceChangeVolumeBuyerSellerMarkers
13:11:14U0.09-0.0052,0002 RBC80 National BankK
13:11:14U0.09-0.0052,0002 RBC80 National BankK
13:11:14U0.09-0.0052,0002 RBC80 National BankK
13:11:14U0.09-0.0052,0002 RBC80 National BankK
13:11:14C0.09-0.0056,0007 TD Sec80 National BankK
13:11:14C0.09-0.00524,00019 Desjardins80 National BankK
13:11:14C0.09-0.0055,00080 National Bank80 National BankK
12:53:22H0.09-0.0054,0001 Anonymous80 National BankK
12:53:15H0.09-0.00525,0001 Anonymous79 CIBCK
12:53:15O0.09-0.0054,0002 RBC80 National BankK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-01-14 18:13C:PHRM0.095News ReleasePharmather enters obesity market with PharmaPatch
2026-01-02 16:52C:PHRM0.10Shareholders LetterPharmather Holdings CEO recaps 2025 work
2025-12-02 20:01C:PHRM0.12News ReleasePharmather closes sale of ketamine ANDA
2025-11-17 18:18C:PHRM0.14News ReleasePharmather Holdings signs evaluation deal with Oakwood
2025-10-30 18:12C:PHRM0.11SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-10-30 18:12C:PHRM0.11SEDAR Interim MD & ASEDAR Interim MD & A
2025-10-17 08:27C:PHRM0.135News ReleasePharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale
2025-10-16 18:13C:PHRM0.135News ReleasePharmather preparing phase 3 FDA package for ketamine
2025-10-15 17:13C:PHRM0.15News ReleasePharmather touts "discovery platform" KetAImine
2025-10-08 18:14C:PHRM0.17News ReleasePharmather talks ketamine as Parkinson's treatment
2025-10-02 16:47C:PHRM0.21News ReleasePharmather clarifies sale of one generic ketamine asset
2025-10-01 18:02C:PHRM0.195News ReleasePharmather signs definitive deal to sell ketamine ANDA
2025-09-26 17:04C:PHRM0.38SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-09-26 17:04C:PHRM0.38SEDAR MD & ASEDAR MD & A
2025-08-27 17:27C:PHRM0.39News ReleasePharmather Holdings advances KETARx after FDA approval
2025-08-26 17:24C:PHRM0.385News ReleasePharmather Holdings hoping for big things from KETARx
2025-08-14 17:57C:PHRM0.45Shareholders LetterPharmather CEO issues letter after KETARx FDA approval
2025-08-11 18:47C:PHRM0.53News ReleasePharmather's KETARx approved by FDA
2025-08-11 09:39C:PHRM0.50News ReleaseCanadian Investment Regulatory Organization Trade Resumption - PHRM
2025-08-08 14:07C:PHRM0.54News ReleaseCanadian Investment Regulatory Organization Trading Halt - PHRM